Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial

BACKGROUND: Efforts to improve the outcome of liver surgery by combining curative resection with chemotherapy have failed to demonstrate definite overall survival benefit. This may partly be due to the fact that these studies often involve strict inclusion criteria. Consequently, patients with a hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayez, Ninos, van der Stok, Eric P, de Wilt, Hans, Radema, Sandra A, van Hillegersberg, Richard, Roumen, Rudi M, Vreugdenhil, Gerard, Tanis, Pieter J, Punt, Cornelis J, Dejong, Cornelis H, Jansen, Rob L, Verheul, Henk M, de Jong, Koert P, Hospers, Geke A, Klaase, Joost M, Legdeur, Marie-Cecile, van Meerten, Esther, Eskens, Ferry A, van der Meer, Nelly, van der Holt, Bruno, Verhoef, Cornelis, Grünhagen, Dirk J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377036/
https://www.ncbi.nlm.nih.gov/pubmed/25884448
http://dx.doi.org/10.1186/s12885-015-1199-8

Ejemplares similares

Ejemplares similares